Literature DB >> 7890884

Hepatitis E: intrafamilial transmission versus waterborne spread.

R Aggarwal1, S R Naik.   

Abstract

The relative significance of intrafamilial transmission and continued water contamination in the spread of hepatitis E is not known. To resolve this question, two surveys were conducted during a large bimodal waterborne epidemic of hepatitis E in Kanpur, India, affecting an estimated 79,000 persons: i) April 1991: covering 420 houses (60 houses each in seven municipal wards) selected using multistage sampling and random number tables, and ii) May 1992: covering the same families in five municipal wards with incidence rates exceeding 1.5% in the first survey. The number of affected cases in each family and the time of onset of disease in each case were recorded. The time interval between the first ('index') case and the subsequent ('later') case(s) in each family was calculated. The temporal relationship of the occurrence of cases was correlated with the time of control of water contamination. One hundred and eleven hepatitis cases occurred in the 343 families (with 2018 members) studied. Eighty-one of these were single or first cases in their families. Twenty-two 'later' cases occurred within 2 weeks (minimum incubation period of hepatitis E) of the 'index' cases and could not be due to intrafamilial transmission. Thus, 103 of 111 (92.8%) cases were due to primary waterborne infection. Eight 'later' cases (7.2% of 111) that occurred 2-6 weeks after the index cases could be due either to direct spread or to intrafamilial transmission. No 'later' case occurred more than 6 weeks after the 'index' cases. New cases stopped appearing 9 weeks (upper limit of incubation period of hepatitis E) after steps to check water contamination were taken.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 7890884     DOI: 10.1016/s0168-8278(94)80229-7

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  13 in total

Review 1.  Hepatitis e: epidemiology and natural history.

Authors:  Rakesh Aggarwal
Journal:  J Clin Exp Hepatol       Date:  2013-06-10

2.  [Incidence of sporadic hepatitis E in Ivory Coast based on still problematic serology].

Authors:  M Rioche; P Dubreuil; A Kouassi-Samgare; V Akran; P Nordmann; J Pillot
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

3.  T-cell epitope mapping of ORF2 and ORF3 proteins of human hepatitis E virus.

Authors:  R Aggarwal; R Shukla; S Jameel; S Agrawal; P Puri; V K Gupta; A P Patil; S Naik
Journal:  J Viral Hepat       Date:  2007-04       Impact factor: 3.728

4.  Overview of Hepatitis E Virus.

Authors:  Susan Skidmore
Journal:  Curr Infect Dis Rep       Date:  2002-04       Impact factor: 3.725

5.  An ethanol extract of Lysimachia mauritiana exhibits inhibitory activity against hepatitis E virus genotype 3 replication.

Authors:  Seong Eun Jin; Jung-Eun Kim; Sun Yeou Kim; Bang Ju Park; Yoon-Jae Song
Journal:  J Microbiol       Date:  2017-12-07       Impact factor: 3.422

Review 6.  Chronic hepatitis E: A brief review.

Authors:  Arvind R Murali; Vikram Kotwal; Saurabh Chawla
Journal:  World J Hepatol       Date:  2015-09-08

Review 7.  Zoonotic hepatitis E: animal reservoirs and emerging risks.

Authors:  Nicole Pavio; Xiang-Jin Meng; Christophe Renou
Journal:  Vet Res       Date:  2010-04-02       Impact factor: 3.683

Review 8.  New perspectives on hepatitis E.

Authors:  Kenneth C Hyams
Journal:  Curr Gastroenterol Rep       Date:  2002-08

9.  Hepatitis E virus epidemiology in industrialized countries.

Authors:  Pilar Clemente-Casares; Sonia Pina; Maria Buti; Rosend Jardi; Margarita MartIn; Sílvia Bofill-Mas; Rosina Girones
Journal:  Emerg Infect Dis       Date:  2003-04       Impact factor: 6.883

10.  An exploratory case control study of risk factors for hepatitis E in rural Bangladesh.

Authors:  Alain B Labrique; K Zaman; Zahid Hossain; Parimalendu Saha; Mohammad Yunus; Anowar Hossain; John Ticehurst; Brittany Kmush; Kenrad E Nelson
Journal:  PLoS One       Date:  2013-05-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.